Breast Biopsy Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Increase in the global breast cancer prevalence rate, changes in lifestyle such as consumption of tobacco, alcohol and food habits, growing in the female population with hormonal imbalance, an increase in the breast cancer screening programs around the globe are anticipated to fuel the breast biopsy devices market over the forecast period. In addition, technological advancements with minimally invasive or non-invasive diagnostic procedure, favourable reimbursement policies, and rising investment by the companies for R&D activities are expected to boost the breast biopsy devices market. However, stringent regulatory guidelines, infections associated with the breast biopsy devices, and the high cost of the procedures are dampening the growth of breast biopsy devices market.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-breast-biopsy-devices-market/#ulp-4H8Z4LpNMLEuOnnx


Breast biopsy devices market segmented based on device type, procedure type, guidance type, and end user

Based on the device type, breast biopsy devices market is segmented into the following:
• Needles
• Forceps
• Guns
• Others

Based on the procedure type, breast biopsy devices market is segmented into the following:
• Core needle biopsy
• Vacuum-assisted core biopsy
• Fine needle aspiration biopsy
• Stereotactic core needle biopsy
• Surgical biopsy
• Others

Based on guidance type, breast biopsy devices market is segmented into the following:
• Ultrasound-guided biopsy
• Magnetic resonance imaging (MRI) guided biopsy
• Mammography guided stereotactic guided biopsy
• Others

Based on the end user, breast biopsy devices market is segmented into the following:
• Hospitals
• Clinics
• Ambulatory surgical centres
• Laboratories

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-breast-biopsy-devices-market/#ulp-c654SbFYO64MsOhu


Breast biopsy devices market is growing at a significant CAGR over the forecast period. The breast biopsy is mandatory for the diagnosis of breast cancer which cannot be confirmed by breast mammograms. Increase in the global breast cancer incidences (according to World Cancer Research Fund International, about 1.7 Mn new cases were observed in 2012) propels the breast cancer devices market over the forecast period. Acquisitions and mergers, collaborations, patent approvals, and technological advancements are the key strategies followed by the companies for increasing their revenue in the breast biopsy devices market. For instance, in 2014, Leica Biosystems (Danaher Corporation) acquired Devicor Medical Products for strengthening its breast biopsy devices portfolio. Moreover, In January 2015, Intact Medical Corporation received FDA approval for the minimally-invasive breast biopsy device. In addition, fundraising by the start-up companies for the innovation of novel devices also propels the breast biopsy devices market over the forecast period.

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-breast-biopsy-devices-market/#ulp-14mlyhjMGhVjZqa3

Geographically, breast biopsy devices market is segmented into Europe, Latin America, North America, Middle East & Africa, and Asia Pacific. North America has a lucrative growth in breast biopsy devices market owing to increase in the prevalence of breast cancer (according to Centre for Disease Control and Prevention 2014, about 236,968 women and 2,141 men were diagnosed with breast cancer in U.S.), technological advancements, and increase in healthcare expenditure in the region. Europe has a significant share owing to rise in prevalence of breast cancer majorly in Italy, Greece, Finland, Germany, and Netherlands where the prevalence rate is approximately more than 400 per 100,000 population. In addition, high adoption of novel technologies, development in healthcare infrastructure, changes in lifestyle, and government initiations to create awareness about breast cancer diagnosis programs are anticipated to fuel the breast biopsy devices market. Asia Pacific is an emerging region for the breast biopsy devices market due to rise in female geriatric population majorly in Japan, China, and India. Moreover, increase in per capita income, rise in awareness about the breast cancer diagnosis, and rise in R&D for developing the minimally invasive procedures are driving the breast biopsy devices market.


Some of the players in breast biopsy devices market are Medtronic, Inc. (Ireland), Becton, Dickinson and Company (U.S.), Hologic Inc. (U.S.), C.R. Bard, Inc. (U.S.), Planmed Oy (Finland), Scion Medical Technologies, LLC (U.S.), and Leica Biosystems (Danaher Corporation) to name a few.

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-breast-biopsy-devices-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.